about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsNew steroids and new salicylates in inflammatory bowel disease: a critical appraisalIndications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Medical management of Crohn's disease.Medical therapies for ulcerative colitis and Crohn's disease.Prevention of relapse of Crohn's disease.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.Treatment of inflammatory bowel disease in childhood: best available evidence.Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.Guidelines for the management of inflammatory bowel disease in adults.Standards of medical treatment and nutrition in Crohn's disease.Management of ulcerative colitis and Crohn's disease.Treatment of postoperative Crohn's disease.Postoperative management of ulcerative colitis and Crohn's disease.Systematic review: the use of mesalazine in inflammatory bowel disease.Review article: can post-operative recurrence in Crohn's disease be prevented?Drug insight: aminosalicylates for the treatment of IBD.Maintenance of surgically induced remission of Crohn's disease.Alternative strategies for the use of infliximab in pediatric inflammatory bowel disease.Postoperative Crohn's disease recurrence: a practical approachPostoperative Crohn's disease: prevention and treatment.Postoperative recurrent luminal Crohn's disease: a systematic review.Mucosal healing in Crohn's disease: a systematic review.The evolving management of postoperative Crohn's disease.Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence.Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.
P2860
Q22242050-34D9D3CD-0B78-44C3-9465-4779EBAA2013Q28192793-F47906F5-4992-49B2-8C20-12248803FCE8Q33868970-36A2F967-DA66-4171-ABD3-6FD2283D972EQ34046139-740A2284-36C9-4CD0-A21A-D5AC73B94F12Q34082723-6099EE3B-3AD8-438D-B6F5-5C07DA9B3B0EQ34125555-AE4316FF-38CE-40EE-9F27-E5BA84E2C4A6Q34152778-BC0825BD-0AF1-4BB4-AE78-785598D5F635Q34429640-3D2A2797-26F3-437E-9440-251B969CEEA0Q35091746-7BB22841-2903-47A7-907B-040C2E4438B7Q35145023-523C6A36-EA91-494C-9B28-6DD5BEF0E3D9Q35790559-499653DF-2CB9-4283-BCF6-73B38AD65794Q35902007-B303B729-F016-4EFA-B615-01181A4950A0Q36004867-F1F7599D-5645-40D6-A9BF-4152A26C87B7Q36041737-838871D4-42B8-412F-989D-037B08F50751Q36325184-4A49EF98-FF4F-4CD7-AC4A-5D282C73C1D7Q36435889-4E13B445-B207-4309-A2C6-C36042420A8EQ36589399-3C3636F4-A0BF-4E2A-A8BA-1D9AAAB971C1Q36752659-6D786FF6-770B-4B98-B0B4-F2DB2EF43C94Q37073415-84BC9856-29BB-4749-82A2-B7F66C9831B1Q37215524-77C86A9A-5F0D-493A-A90C-FDF80CCAACFDQ37276985-D283166A-E9A1-479F-B6EB-F266F2F0F223Q37503371-750C7D30-1681-497A-9728-BB1DD1497EF0Q37914790-4D395659-4504-409B-AA09-AD6BABD1892CQ38005972-4A310F9C-68F6-42E2-AA88-673DC5EFE593Q38051707-9395D45A-0B01-4B9E-BFCC-83F0AA0358F5Q38538894-49E31EB6-1666-4BFB-8B57-8AE02D4226EEQ44352708-E6CE8CB2-4D4E-40A9-B7DF-E929379B90C0
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Mesalamine and relapse prevention in Crohn's disease.
@en
Mesalamine and relapse prevention in Crohn's disease.
@nl
type
label
Mesalamine and relapse prevention in Crohn's disease.
@en
Mesalamine and relapse prevention in Crohn's disease.
@nl
prefLabel
Mesalamine and relapse prevention in Crohn's disease.
@en
Mesalamine and relapse prevention in Crohn's disease.
@nl
P356
P1433
P1476
Mesalamine and relapse prevention in Crohn's disease.
@en
P2093
P356
10.1053/GAST.2000.16153
P407
P577
2000-08-01T00:00:00Z